Crescent Biopharma Inc (CBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -153,942 | -17,867 | -36,899 | -46,689 | -63,427 |
| Depreciation Amortization | 84 | N/A | 153 | 207 | 265 |
| Accounts receivable | -18,000 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -5,000 | 7,328 | -102 | -1,137 | 18 |
| Other Working Capital | -13,371 | 9,462 | -2,559 | -4,662 | -1,165 |
| Other Operating Activity | 118,697 | -5,192 | 4,527 | 5,824 | 6,821 |
| Operating Cash Flow | $-71,532 | $-6,269 | $-34,880 | $-46,458 | $-57,490 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -919 | N/A | -21 | -84 | -15 |
| Other Investing Activity | -72,000 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-72,919 | $N/A | $-21 | $-84 | $-15 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 37,480 | N/A | N/A | N/A |
| Common Stock Issued | 5 | 315 | 28,824 | 4,157 | 10,724 |
| Common Stock Repurchased | -177 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 323,156 | 3,240 | 0 | 0 | 0 |
| Financing Cash Flow | $322,984 | $41,035 | $28,824 | $4,157 | $10,724 |
| Beginning Cash Position | 34,766 | 0 | 47,871 | 90,255 | 137,035 |
| End Cash Position | 213,299 | 34,766 | 41,793 | 47,871 | 90,255 |
| Net Cash Flow | $178,533 | $34,766 | $-6,078 | $-42,384 | $-46,780 |
| Free Cash Flow | |||||
| Operating Cash Flow | -71,532 | -6,269 | -34,880 | -46,458 | -57,490 |
| Capital Expenditure | -919 | 0 | -21 | -84 | -15 |
| Free Cash Flow | -72,451 | -6,269 | -34,901 | -46,542 | -57,504 |